Nifty

:

11600.20

Sensex

:

39090.03

326.00 (2.89%)
1075.41 (2.83%)

Login

Nifty
Sensex

:
:

11600.20
39090.03

326.00 (2.89%)
1075.41 (2.83%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

58/99

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

86.15

23-Sep-2019

Open
High
Low
Previous Close

85.35
89.60
82.20
87.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4013
3.47
130.18
61.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

147.93
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

183.99
N/A
-6.76

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.33
-
138.28

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
14.78
4.06

PAT CAGR (%)

10 Years
5 Years
3 Years

13.44
20.61
7.63

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-1.49
-3.81
-15.71

EV:EBITDA (Average)

8 Years
5 Years
3 Years

2.77
-18.19
-30.75

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 4.66 8.95 -47.93% 11.71 10.21 14.69% 11.34 19.42 -41.61% 15.76 3.00 425.33%
Expenses 9.67 11.74 -17.63% 14.11 15.02 -6.06% 15.40 15.82 -2.65% 16.32 5.60 191.43%
EBITDA -5.01 -2.80 - -2.40 -4.82 - -4.05 3.60 - -0.56 -2.60 -
EBIDTM -107.53% -31.27% -20.53% -47.19% -35.74% 18.52% -3.54% -86.45%
Other Income 0.18 0.03 500.00% 0.16 0.15 6.67% 0.12 0.01 1,100.00% 0.02 0.00 0.00
Interest 1.61 1.42 13.38% 1.90 1.42 33.80% 1.46 1.42 2.82% 1.46 1.24 17.74%
Depreciation 1.15 1.07 7.48% 1.18 1.09 8.26% 1.07 1.02 4.90% 1.07 1.02 4.90%
PBT -7.59 -5.26 - -5.21 -7.47 - -6.46 0.44 - -3.07 -4.86 -
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -7.59 -5.26 - -5.21 -7.47 - -6.46 0.44 - -3.07 -4.86 -
PATM -162.81% -58.85% -44.48% -73.23% -56.98% 2.28% -19.51% -161.78%
EPS -4.56 -3.70 - -3.13 -5.25 - -4.54 0.31 - -2.16 -3.42 -

Description Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11 Mar 10
Net Sales 43.47 47.76 33.78 3.53 1.29 0.00 0.00 11.45 70.76 72.44 46.23 Net Sales Growth 4.55% 41.39% 856.94% 173.64% 0 0 -100% -83.82% -2.32% 56.69% Cost Of Goods Sold 21.00 23.10 12.67 1.20 0.14 0.00 0.00 4.61 38.70 40.69 18.64 Gross Profit 22.47 24.65 21.10 2.33 1.14 0.00 0.00 6.83 32.06 31.76 27.59 GP Margin 51.69% 51.61% 62.46% 66.01% 88.37% 0 0 59.65% 45.31% 43.84% 59.68% Total Expenditure 55.50 57.52 41.28 11.53 13.69 4.90 4.04 24.63 74.54 72.24 44.11 Power & Fuel Cost - 11.70 8.62 0.70 2.87 0.28 1.87 6.24 18.79 12.99 9.19 % Of Sales - 24.50% 25.52% 19.83% 222.48% 0 0 54.50% 26.55% 17.93% 19.88% Employee Cost - 14.41 11.49 5.63 5.67 1.86 0.55 9.08 8.77 8.28 6.62 % Of Sales - 30.17% 34.01% 159.49% 439.53% 0 0 79.30% 12.39% 11.43% 14.32% Manufacturing Exp. - 4.09 4.59 1.07 1.62 0.62 0.04 1.76 3.57 4.27 3.06 % Of Sales - 8.56% 13.59% 30.31% 125.58% 0 0 15.37% 5.05% 5.89% 6.62% General & Admin Exp. - 4.05 3.76 2.88 3.33 2.14 1.54 2.57 2.36 2.46 2.18 % Of Sales - 8.48% 11.13% 81.59% 258.14% 0 0 22.45% 3.34% 3.40% 4.72% Selling & Distn. Exp. - 0.13 0.13 0.05 0.04 0.00 0.01 0.29 2.31 2.42 2.29 % Of Sales - 0.27% 0.38% 1.42% 3.10% 0 0 2.53% 3.26% 3.34% 4.95% Miscellaneous Exp. - 0.02 0.02 0.01 0.02 0.00 0.03 0.06 0.04 1.11 2.29 % Of Sales - 0.04% 0.06% 0.28% 1.55% 0 0 0.52% 0.06% 1.53% 4.56% EBITDA -12.02 -9.76 -7.50 -8.00 -12.40 -4.90 -4.04 -13.18 -3.78 0.20 2.12 EBITDA Margin -27.65% -20.44% -22.20% -226.63% -961.24% 0 0 -115.11% -5.34% 0.28% 4.59% Other Income 0.48 0.33 0.21 0.08 1.03 0.01 0.18 6.14 2.75 7.02 0.03 Interest 6.43 6.29 5.17 3.49 0.74 4.03 0.08 0.63 8.66 7.52 6.95 Depreciation 4.47 4.40 4.15 4.23 4.49 1.87 0.00 8.28 9.66 9.60 9.88 PBT -22.33 -20.12 -16.61 -15.65 -16.60 -10.79 -3.95 -15.94 -19.34 -9.89 -14.68 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.74 -1.90 -3.21 -9.01 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -10.13% 4.64% 9.82% 32.46% 61.38% PAT -22.33 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 -17.44 -6.68 -5.67 PAT before Minority Interest -22.33 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 -17.44 -6.68 -5.67 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -51.37% -41.90% -52.75% -454.67% -1265.12% 0 0 -132.75% -24.65% -9.22% -12.26% PAT Growth 0.00% - - - - - - - - - Unadjusted EPS -14.39 -12.83 -14.01 -8.39 -13.24 -8.24 -4.57 -15.98 -18.33 -7.38 -6.26

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds -14.29 -17.78 1.48 13.01 18.28 3.60 7.95 23.15 40.59 45.97 Share Capital 16.63 13.74 13.74 13.06 9.51 9.51 9.51 9.51 9.05 9.05 Total Reserves -30.92 -31.52 -12.27 -3.72 -14.08 -5.91 -1.57 13.64 30.24 36.92 Non-Current Liabilities 101.79 98.68 88.88 73.88 60.12 23.02 57.33 65.53 73.31 90.97 Secured Loans 0.00 1.89 5.03 21.40 14.00 15.00 48.70 59.09 64.94 75.67 Unsecured Loans 50.23 49.78 37.76 3.91 43.61 7.32 8.35 5.67 5.91 11.05 Long Term Provisions 4.04 3.68 2.82 3.57 3.83 2.02 2.00 1.74 1.53 0.00 Current Liabilities 54.86 44.98 31.72 29.52 28.72 109.84 70.64 58.93 42.91 20.86 Trade Payables 21.46 17.76 10.99 12.37 16.54 19.79 19.75 27.34 20.98 15.71 Other Current Liabilities 31.97 25.97 19.86 16.34 12.09 84.67 31.92 16.26 6.48 3.86 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 3.48 18.73 15.17 15.13 0.00 Short Term Provisions 1.43 1.25 0.87 0.82 0.09 1.90 0.24 0.16 0.33 1.29 Total Liabilities 142.36 125.88 122.08 116.41 107.12 136.46 135.92 147.61 156.81 157.80 Net Block 101.27 102.32 102.17 93.10 50.98 50.58 50.63 58.47 66.14 68.79 Gross Block 234.41 231.06 226.55 213.24 166.84 164.25 164.31 163.87 161.88 154.94 Accumulated Depreciation 133.15 128.74 124.38 120.14 115.86 113.66 113.67 105.40 95.74 86.15 Non Current Assets 111.39 108.64 109.10 107.03 92.26 97.66 97.49 104.59 108.58 72.47 Capital Work in Progress 3.48 2.19 3.50 10.54 7.46 7.13 7.13 6.96 5.00 3.69 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 6.22 3.93 3.23 3.19 33.82 39.95 39.73 39.16 37.45 0.00 Other Non Current Assets 0.41 0.20 0.20 0.20 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 30.98 17.24 12.97 9.39 14.87 38.81 38.43 43.02 48.23 80.33 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 8.96 11.73 5.45 5.64 5.45 30.82 30.82 30.49 29.40 29.37 Sundry Debtors 2.91 0.32 1.59 0.03 0.37 0.62 0.92 7.74 13.39 28.27 Cash & Bank 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 0.51 Other Current Assets 1.78 0.33 0.14 0.08 2.74 7.01 6.35 4.36 5.08 22.18 Short Term Loans & Adv. 1.57 4.44 5.67 3.38 0.59 5.41 4.91 2.88 4.15 22.18 Net Current Assets -23.88 -27.74 -18.74 -20.14 -13.86 -71.03 -32.21 -15.92 5.32 59.47 Total Assets 142.37 125.88 122.07 116.42 107.13 136.47 135.92 147.61 156.81 157.80

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity -3.67 -7.15 -11.20 -15.26 -45.26 49.24 -1.55 7.32 -4.62 -15.51 PBT -20.12 -17.82 -16.05 -16.60 -10.79 -4.10 -15.94 -19.34 -9.89 -14.76 Adjustment 9.10 6.39 10.67 3.45 8.84 0.22 2.76 15.56 10.05 13.21 Changes in Working Capital 13.59 9.46 -2.33 -1.38 -39.28 54.65 12.37 19.82 1.61 -7.06 Cash after chg. in Working capital 2.57 -1.98 -7.71 -14.53 -41.23 50.76 -0.81 16.04 1.78 -8.61 Interest Paid -6.24 -5.17 -3.49 -0.74 -4.03 -1.53 -0.63 -8.66 -7.47 -6.90 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 -0.11 -0.06 1.07 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.32 -1.48 -4.70 -4.00 -2.92 0.07 5.54 -1.20 3.76 11.55 Net Fixed Assets -4.64 -3.20 -6.27 -49.48 -2.92 0.06 -0.61 -3.95 -8.25 11.72 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.32 1.72 1.57 45.48 0.00 0.01 6.15 2.75 12.01 -0.17 Cash from Financing Activity 24.88 8.93 15.75 13.22 54.13 -49.28 -4.09 -6.06 0.72 4.05 Net Cash Inflow / Outflow 16.90 0.30 -0.15 -6.04 5.95 0.03 -0.10 0.07 -0.14 0.09 Opening Cash & Equivalents 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 0.51 0.42 Closing Cash & Equivalent 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 0.51

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) -8.59 -12.49 1.04 6.91 -4.63 3.66 8.07 23.50 41.93 43.73 ROA -14.92% -14.38% -13.46% -14.60% -6.44% -3.19% -10.72% -11.46% -4.25% -3.44% ROE 0.00% 0.00% -296.70% -683.34% 0.00% -75.26% -97.77% -55.86% -16.65% -12.93% ROCE -35.41% -28.95% -27.13% -25.38% -4.33% -3.91% -14.60% -9.06% -1.86% -6.01% Fixed Asset Turnover 0.21 0.15 0.02 0.01 0.00 0.00 0.07 0.47 0.49 0.30 Receivable days 12.36 10.34 83.55 51.87 0.00 0.00 130.58 50.71 97.10 220.67 Inventory Days 79.07 92.84 573.34 1435.63 0.00 0.00 925.22 143.77 137.01 192.97 Payable days 123.25 120.44 290.43 338.13 1500.06 2505.25 277.77 107.23 85.09 103.10 Cash Conversion Cycle -31.81 -17.27 366.46 1149.37 -1500.06 -2505.25 778.03 87.24 149.02 310.53 Total Debt/Equity -3.74 -3.16 32.19 3.27 -13.34 25.86 11.65 3.72 2.19 2.12 Interest Cover -2.18 -2.45 -3.60 -21.09 -0.95 -45.92 -24.33 -1.23 -0.32 -1.11

Top Investors:

sun pharmaceutical industries limited

pinky ventures private limited

shaaji palliyath

Annual Reports:

News Update:

Krebs Biochem.&Inds - Quarterly Results
9th Aug 2019, 17:25 PM

Read More
Krebs Biochemicals receives temporary revocation of stop-production order from APPCB
3rd Aug 2019, 09:46 AM

The company has started production and is also working on complying with the directions by the Board
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback